TAG:
genomics
“May 13, 2002 Intelligence: Late Breaking Lab News”
Guess whose DNA was used by Celera Genomics during its project to map the human genome back in 1999? It was primarily the DNA of J. Craig Ventor, Ph.D., who was Chairman of Celera at that time. The disclosure, made last week, has stirred some controversy. Defenders say it is in the t…
New Lab Test Technology Must Meet Five Payer Requirements
HOSPITALS ARE NOT THE ONLY healthcare player wary of the high cost of new diagnostic test technologies. Insurance companies all over the United States have increased their scrutiny of new medical technology, including laboratory tests. In a visit to Wall Street last week, THE DARK REPORT attended …
AACC’s E-Lab Confab Emphasizes Lab Data
CEO SUMMARY: In just six years, experts at the AACC’s E-Lab gathering predict that 50% of all diagnostic testing will be done as point-of-care, homecare, or kit testing. If true, this will be a swift transformation in how labs organize themselves to manage the diagnostic testing needs o…
“March 11, 2002 Intelligence: Late Breaking Lab News”
Down in Orlando, Florida, Cognescenti Health Institute, now opening a newly-constructed clinical laboratory, has selected LabDat, Inc. to provide browser-based lab test ordering and results reporting. In response to the anticipated changes caused by genomic and prot…
Court Orders Roche to Pay IGEN $505 Million in Damages
IT WAS A BIG COURT WIN for little IGEN International. On January 10, a jury in federal district court in Maryland decided that IGEN could terminate its licensing agreement with Roche Holding AG. The jury also awarded IGEN a total of $505 million, $105 million in com…
IMPATH Buys Tamtron In Surprise Decision
CEO SUMMARY: In an unexpected announcement, IMPATH, Inc. announced it would purchase Tamtron Corp., the largest remaining independent vendor of anatomic pathology systems. It was just months earlier that Cerner Corporation acquired Dynamic Healthcare Technologies, Inc. and its CoPath™ p…
2001’s Ten Big Stories Presage Future Direction
CEO SUMMARY: During 2001, few labs found themselves under intense pressure to change or react to dramatic events in the healthcare marketplace. Like 2000, this past year was marked by evolutionary progress, not revolutionary change. However, continuing signs indicate that consumers will p…
Tripath Imaging Ready To Roil Pap Test Market
CEO SUMMARY: Single-handedly, Cytyc Corporation has built the market for thin-layer Pap smear testing. Executives at TriPath Imaging are now ready to challenge Cytyc’s dominance by offering what they believe is a different value proposition to labs: an automated liquid preparation syste…
New Lab Company Ready To Open In Orlando, FL
CEO SUMMARY: Within the next 60 days, a brand-new clinical laboratory company will begin operations in Orlando, Florida. In the short term, it plans to offer routine testing to physicians’ offices. However, the real goal is to create a laboratory organization with integrated information…
DIANON Systems, United Health, Aetna, Quest Diagnostics, Orchid, AmeriPath
DIANON SYSTEMS INKS NATIONAL AGREEMENT WITH UNITEDHEALTHCARE A NEW NATIONAL AGREEMENT between DIANON Systems, Inc. and UnitedHealthcare was announced last week. The agreement allows DIANON Systems to provide pathology and genetic testing services to all the…
CURRENT ISSUE
Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.